Cita APA (7a ed.)

Jin, L., Tao, H., Karachi, A., Long, Y., Hou, A. Y., Na, M., . . . Huang, J. (2019). CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors. Nature Portfolio.

Cita Chicago Style (17a ed.)

Jin, Linchun, et al. CXCR1- or CXCR2-modified CAR T Cells Co-opt IL-8 for Maximal Antitumor Efficacy in Solid Tumors. Nature Portfolio, 2019.

Cita MLA (8a ed.)

Jin, Linchun, et al. CXCR1- or CXCR2-modified CAR T Cells Co-opt IL-8 for Maximal Antitumor Efficacy in Solid Tumors. Nature Portfolio, 2019.